about
Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve OutcomesManagement of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic controlMitochondrial Glutathione in Diabetic NephropathyThe role of ubiquitination and sumoylation in diabetic nephropathy.A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathyRegression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockadeGetting better at chronic care in remote communities: study protocol for a pragmatic cluster randomised controlled of community based management.Screening for diabetic retinopathy and nephropathy in patients with diabetes: a nationwide survey in Korea.Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based studyDoes antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.Tuberin inhibits production of the matrix protein fibronectin in diabetesTight blood glucose control is renoprotective in critically ill patientsIncreased risk of CKD among type 2 diabetics with nonalcoholic fatty liver diseaseChanging course of diabetic nephropathy in the Pima Indians.Effects of chronic PPAR-agonist treatment on cardiac structure and function, blood pressure, and kidney in healthy sprague-dawley rats.Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal eventsLifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan.Non-aristolochic acid prescribed Chinese herbal medicines and the risk of mortality in patients with chronic kidney disease: results from a population-based follow-up study.Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective.Erk5 is a mediator to TGFβ1-induced loss of phenotype and function in human podocytes.Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability.Tight glycemic control and cardiovascular effects in type 2 diabetic patients.Glycemic status and chronic kidney disease in Chinese adults: Findings from the REACTION study.Association of Diabetic Neuropathy with Duration of Type 2 Diabetes and Glycemic Control.Body weight control by a high-carbohydrate/low-fat diet slows the progression of diabetic kidney damage in an obese, hypertensive, type 2 diabetic rat model.Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathyThe effect of 12 weeks carnosine supplementation on renal functional integrity and oxidative stress in pediatric patients with diabetic nephropathy: a randomized placebo-controlled trial.Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes.CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.Inhibition to DRP1 translocation can mitigate p38 MAPK-signaling pathway activation in GMC induced by hyperglycemia.Insulin, glucose control and multiple organ dysfunction syndromelectin alleviates diabetic nephropathy by inhibiting the LOX1/NF-κB/caspase-9 signaling pathway
P2860
Q26744419-C24C0919-54BB-4FB3-BC64-71E756B02B2CQ26766259-8C6A0CDF-D1B8-470F-B0F3-69C7CF87FC07Q26799424-665492B2-9D87-4FD5-8295-5D91B1E2E01DQ33786922-A9E92B78-6D66-43A6-AEE5-422D0CB91683Q33932800-05AD71D3-BF22-4084-9A41-7DFA1BAD2FB3Q34203622-60BF331C-5515-4934-BB8C-E962FD074196Q34484248-60EB4F9D-506F-478B-9DF6-E091279CABC9Q34717944-6C7D8FB8-D2D7-4177-9FD2-9DC6C70725A3Q35106469-AF09FFC3-5A77-4DBC-B858-C58B2B9F4C6CQ35771271-DA77DFED-5D46-472F-8FFB-F14F9510BE80Q36111664-1741D33D-4760-4755-B9DE-03A8DDAFEEE2Q36280377-E0917F21-385E-43D3-B5FC-90647B3D2783Q36667192-EE17E952-E599-49DD-AA60-FBC3DE263304Q36796750-ECB4D684-03A4-4A98-B525-ECF2971FAD6DQ37016109-5719DCA3-8233-4820-8DD6-BDEA38299C34Q37227064-3DE8A1FA-8DA7-43C0-A905-5B78F52591AEQ37282849-0FB1E529-B74F-4137-9588-5D682B1A9523Q37389816-361E87A7-7BD3-43F6-8AF6-708C4294DAE0Q37598068-576E5E3A-B8AE-4621-818D-610355918C6FQ37721470-BB151FF5-2199-4238-994A-C0E5FC7E7D51Q37725607-40DAAE26-4256-4C51-A6DC-1B11904B1C6DQ37910988-2045477D-C8A3-480E-89BA-B0923333725EQ38379445-428CD2F8-3C72-4B6F-93DC-F520EADEE66FQ39296877-21CEAF00-F84A-4107-A52B-56AAC458950BQ40474030-F96F8CEE-B565-43F2-A0B0-D70DCBC361F4Q41828830-F7E7D612-D975-49B4-AF97-5351DB9FA0A0Q42364411-0CFD4ACF-1F4C-4D7D-B188-D9641815BECAQ46330764-5C71D8F2-0D65-4715-A5AA-1DA4D22C2742Q48141985-0FB1304A-69A4-4334-BD00-578DDAFDB9D2Q51659952-0775DB73-1C1B-4E03-8E0D-3DD77D583699Q52952699-0DF2BFC8-5EAE-4C0C-990E-4D8EDADC0DBBQ57245133-D18EB17F-5E5C-4849-9237-85457580CAF9Q58760376-2959A946-857F-4B63-9FEA-18FEE8494CB0
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Renal protection in diabetes: role of glycemic control.
@ast
Renal protection in diabetes: role of glycemic control.
@en
type
label
Renal protection in diabetes: role of glycemic control.
@ast
Renal protection in diabetes: role of glycemic control.
@en
prefLabel
Renal protection in diabetes: role of glycemic control.
@ast
Renal protection in diabetes: role of glycemic control.
@en
P2093
P356
P1476
Renal protection in diabetes: role of glycemic control
@en
P2093
Enzo Manzato
Ilaria Berto
Marino Bruseghin
Paola Fioretto
Pietro Gallina
P356
10.1681/ASN.2005121343
P433
P577
2006-04-01T00:00:00Z